Ying Tan

2.4k total citations · 3 hit papers
36 papers, 1.7k citations indexed

About

Ying Tan is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ying Tan has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Epidemiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ying Tan's work include Mitochondrial Function and Pathology (11 papers), Autophagy in Disease and Therapy (10 papers) and Inflammasome and immune disorders (5 papers). Ying Tan is often cited by papers focused on Mitochondrial Function and Pathology (11 papers), Autophagy in Disease and Therapy (10 papers) and Inflammasome and immune disorders (5 papers). Ying Tan collaborates with scholars based in China, United States and Hong Kong. Ying Tan's co-authors include Maolong Dong, Xiaochan Xiao, Jiankai Zhong, Sainan Chen, Hao Zhou, Jun Ren, Jing He, Chen Cai, Qi Wu and Feng Wu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Ying Tan

36 papers receiving 1.7k citations

Hit Papers

Deletion of TLR4 attenuates lipopolysaccharide-induced ac... 2021 2026 2022 2024 2021 2022 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Tan China 22 927 402 238 204 201 36 1.7k
Haixia Xu China 23 809 0.9× 379 0.9× 196 0.8× 138 0.7× 137 0.7× 63 1.7k
Hala O. El‐Mesallamy Egypt 27 689 0.7× 388 1.0× 305 1.3× 148 0.7× 275 1.4× 78 1.8k
Qinghua Lu China 26 988 1.1× 229 0.6× 263 1.1× 206 1.0× 116 0.6× 70 1.9k
Xing Chang China 26 1.3k 1.4× 529 1.3× 200 0.8× 158 0.8× 279 1.4× 56 2.2k
Huixia Lu China 21 815 0.9× 435 1.1× 208 0.9× 192 0.9× 318 1.6× 76 1.8k
Hongxia Wang China 27 653 0.7× 298 0.7× 201 0.8× 290 1.4× 134 0.7× 90 1.8k
Hang Zhu China 19 896 1.0× 543 1.4× 170 0.7× 152 0.7× 165 0.8× 37 1.7k
Zhisheng Jiang China 25 778 0.8× 276 0.7× 355 1.5× 318 1.6× 143 0.7× 85 1.8k
Zhuoming Li China 19 710 0.8× 250 0.6× 166 0.7× 243 1.2× 206 1.0× 42 1.5k

Countries citing papers authored by Ying Tan

Since Specialization
Citations

This map shows the geographic impact of Ying Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Tan more than expected).

Fields of papers citing papers by Ying Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Tan. The network helps show where Ying Tan may publish in the future.

Co-authorship network of co-authors of Ying Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Tan. A scholar is included among the top collaborators of Ying Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Tan. Ying Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Mengyuan, et al.. (2024). PKM2 interacts with and phosphorylates PHB2 to sustain mitochondrial quality control against septic cerebral-cardiac injury. International Journal of Medical Sciences. 21(4). 633–643. 2 indexed citations
2.
Ma, Li, et al.. (2023). Transmembrane BAX inhibitor motif containing 6 suppresses presenilin-2 to preserve mitochondrial integrity after myocardial ischemia-reperfusion injury. International Journal of Biological Sciences. 19(4). 1228–1240. 5 indexed citations
3.
Cai, Chen, Feng Wu, Jing He, et al.. (2022). Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies. International Journal of Biological Sciences. 18(14). 5276–5290. 43 indexed citations
4.
Cai, Chen, Feng Wu, Nengxian Shi, et al.. (2022). Empagliflozin activates Wnt/β-catenin to stimulate FUNDC1-dependent mitochondrial quality surveillance against type-3 cardiorenal syndrome. Molecular Metabolism. 64. 101553–101553. 22 indexed citations
5.
Tan, Ying, et al.. (2022). cGAS-STING signaling in ischemic diseases. Clinica Chimica Acta. 531. 177–182. 16 indexed citations
6.
Cai, Chen, Zhongzhou Guo, Xing Chang, et al.. (2022). Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway. Redox Biology. 52. 102288–102288. 159 indexed citations breakdown →
7.
Li, Ting, et al.. (2021). Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene. 808. 145968–145968. 153 indexed citations
8.
Chen, Sainan, Ying Tan, Xiaochan Xiao, et al.. (2021). Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis. Acta Pharmacologica Sinica. 42(10). 1610–1619. 160 indexed citations breakdown →
9.
Li, Qian, Nengxian Shi, Chen Cai, et al.. (2021). The Role of Mitochondria in Pyroptosis. Frontiers in Cell and Developmental Biology. 8. 630771–630771. 49 indexed citations
10.
Li, Chen, et al.. (2020). Resveratrol Improves Bnip3-Related Mitophagy and Attenuates High-Fat-Induced Endothelial Dysfunction. Frontiers in Cell and Developmental Biology. 8. 796–796. 54 indexed citations
11.
Tan, Ying, Mingming Sun, Wenjing Zhang, et al.. (2020). Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism. Acta Pharmacologica Sinica. 42(3). 404–413. 52 indexed citations
12.
Tan, Ying, et al.. (2020). The Hippo Pathway Orchestrates Mitochondrial Quality Control: A Novel Focus on Cardiovascular Diseases. DNA and Cell Biology. 39(9). 1494–1505. 4 indexed citations
13.
Chen, Sainan, et al.. (2020). AMPKα2 Overexpression Reduces Cardiomyocyte Ischemia-Reperfusion Injury Through Normalization of Mitochondrial Dynamics. Frontiers in Cell and Developmental Biology. 8. 833–833. 4 indexed citations
14.
Tan, Ying, et al.. (2019). Irisin ameliorates septic cardiomyopathy via inhibiting DRP1-related mitochondrial fission and normalizing the JNK-LATS2 signaling pathway. Cell Stress and Chaperones. 24(3). 595–608. 57 indexed citations
16.
Sun, Mingming, et al.. (2018). Obesity is a common soil for premature cardiac aging and heart diseases - Role of autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(7). 1898–1904. 19 indexed citations
18.
Tan, Ying, Yan Gong, Maolong Dong, Zhaohui Pei, & Jun Ren. (2018). Role of autophagy in inherited metabolic and endocrine myopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(1). 48–55. 17 indexed citations
19.
Shen, Jiangang, Ying Tan, Di Tian, et al.. (2014). Heat shock protein 65 promotes atherosclerosis through impairing the properties of high density lipoprotein. Atherosclerosis. 237(2). 853–861. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026